Back to UBS Group AG UBS Group AG

ESPRESPR
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in ESPERION THERAPEUTICS INC NE

UBS Group AG holds 3.8M shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $12.1M as of 2026-Q2. The position was decreased (-10.6% shares). ESPR represents 0.0% of UBS Group AG's portfolio.

Current Value

$12.1M

Current Shares

3.8M

Total Value Change

+$12M

Total Shares Change

+3.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.8M
-10.6%
$12.1M0.0%$3.16
0
2026-Q1
Increased
4.3M
+1269.6%
$11.8M0.0%$2.91
45
2025-Q4
Decreased
313,353
-74.9%
$1.2M0.0%$3.69
0
2025-Q3
Decreased
1.2M
-18.9%
$3.3M0.0%$2.64
0
2025-Q2
Increased
1.5M
+129.5%
$1.5M0.0%$0.99
41
2025-Q1
Decreased
669,918
-23.6%
$964,6820.0%$1.50
0
2024-Q4
Increased
876,942
+871.2%
$1.9M0.0%$2.15
42
2024-Q3
Increased
90,293
+32.4%
$148,9840.0%$1.68
19

Other major holders of ESPR: BNP PARIBAS FINANCIAL MARKETS, Pentwater Capital Management LP, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used